SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-436875
Filing Date
2013-11-12
Accepted
2013-11-12 07:09:33
Documents
5
Period of Report
2013-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d624501d8k.htm 8-K 15409
2 EX-99.1 d624501dex991.htm EX-99.1 63101
3 EX-99.2 d624501dex992.htm EX-99.2 18721
4 GRAPHIC g624501ex99_1logo.jpg GRAPHIC 11726
5 GRAPHIC g624501ex99_2logo.jpg GRAPHIC 11726
  Complete submission text file 0001193125-13-436875.txt   131319
Mailing Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142 857-242-3700
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 131206912
SIC: 2834 Pharmaceutical Preparations